[1]
Gable, J.E.; Acker, T.M.; Craik, C.S. Current and potential treatments for ubiquitous but neglected herpesvirus infections. Chem. Rev., 2014, 114, 11382-11412.
[2]
Tenney, D.J.; Yamanaka, G.; Voss, S.M.; Cianci, C.W.; Tuomari, A.V.; Sheaffer, A.K.; Alam, M.; Colonno, R.J. lobucavir is phosphorylated in human cytomegalovirus-infected and -uninfected cells and inhibits the viral DNA polymerase. Antimicrob. Agent Chemother., 1997, 41, 2680-2685.
[3]
Field, H.J.; Vere Hodge, R.A. Recent developments in anti-herpesvirus drugs. Br. Med. Bull., 2013, 106, 213-249.
[4]
Andrei, G.; Snoeck, R. Advances in the treatment of varicella-zoster virus infections. Adv. Pharmacol., 2013, 67, 107-168.
[5]
Kotton, C.N.; Kumar, D.; Caliendo, A.M.; Asberg, A.; Chou, S.; Snydman, D.R.; Allen, U.; Humar, A. Transplantat Soc Int, C.M.V.C. International consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation, 2010, 89, 779-795.
[6]
Kotton, C.N.; Kumar, D.; Caliendo, A.M.; Asberg, A.; Chou, S.; Danziger-Isakov, L.; Humar, A. Transplantat Soc Int, C.M.V. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation, 2013, 96, 333-360.
[7]
Andrei, G.; De Clercq, E.; Snoeck, R. Drug targets in cytomegalovirus infection. Infect. Disord. Drug Targets, 2009, 9, 201-222.
[8]
Lurain, N.S.; Chou, S. Antiviral drug resistance of human cytomegalovirus. Clin. Microbiol. Rev., 2010, 23, 689-712.
[9]
Melendez, D.P.; Razonable, R.R. Letermovir and inhibitors of the terminase complex: A promising new class of investigational antiviral drugs against human cytomegalovirus. Infect. Drug Resist., 2015, 8, 269-277.
[10]
Marschall, M.; Stamminger, T.; Urban, A.; Wildum, S.; Ruebsamen-Schaeff, H.; Zimmermann, H.; Lischka, P. In vitro evaluation of the activities of the novel anticytomegalovirus compound AIC246 (Letermovir) against herpesviruses and other human pathogenic viruses. Antimicrob. Agents Chemother., 2012, 56, 1135-1137.
[11]
Kaul, D.R.; Stoelben, S.; Cober, E.; Ojo, T.; Sandusky, E.; Lischka, P.; Zimmermann, H.; Rubsamen-Schaeff, H. First report of successful treatment of multidrug-resistant cytomegalovirus disease with the novel anti-CMV compound AIC246. Am. J. Transplant., 2011, 11, 1079-1084.
[12]
Crute, J.J.; Grygon, C.A.; Hargrave, K.D.; Simoneau, B.; Faucher, A.M.; Bolger, G.; Kibler, P.; Liuzzi, M.; Cordingley, M.G. Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease. Nat. Med., 2002, 8, 386-391.
[13]
Kleymann, G.; Fischer, R.; Betz, U.A.K.; Hendrix, M.; Bender, W.; Schneider, U.; Handke, G.; Eckenberg, P.; Hewlett, G.; Pevzner, V.; Baumeister, J.; Weber, O.; Henninger, K.; Keldenich, J.; Jensen, A.; Kolb, J.; Bach, U.; Popp, A.; Maben, J.; Frappa, I.; Haebich, D.; Lockhoff, O.; Rubsamen-Waigmann, H. New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease. Nat. Med., 2002, 8, 392-398.
[14]
Wald, A.; Corey, L.; Timmler, B.; Magaret, A.; Warren, T.; Tyring, S.; Johnston, C.; Kriesel, J.; Fife, K.; Galitz, L.; Stoelben, S.; Huang, M-L.; Selke, S.; Stobernack, H-P.; Ruebsamen-Schaeff, H.; Birkmann, A. Helicase-primase inhibitor pritelivir for HSV-2 infection. Eng. J. Med., 2014, 370, 201-210.
[15]
Reefschlaeger, J.; Bender, W.; Hallenberger, S.; Weber, O.; Eckenberg, P.; Goldmann, S.; Haerter, M.; Buerger, I.; Trappe, J.; Herrington, J.A.; Haebich, D.; Ruebsamen-Waigmann, H. Novel non-nucleoside inhibitors of cytomegaloviruses (BAY 38-4766): In vitro and in vivo antiviral activity and mechanism of action. J. Antimicrob. Chemother., 2001, 48, 757-767.
[16]
Underwood, M.R.; Ferris, R.G.; Selleseth, D.W.; Davis, M.G.; Drach, J.C.; Townsend, L.B.; Biron, K.K.; Boyd, F.L. Mechanism of action of the ribopyranoside benzimidazole GW275175X against human cytomegalovirus. Antimicrob. Agents Chemother., 2004, 48, 1647-1651.
[17]
Ogilvie, W.; Bailey, M.; Poupart, M.A.; Abraham, A.; Bhavsar, A.; Bonneau, P.; Bordeleau, J.; Bousquet, Y.; Chabot, C.; Duceppe, J.S.; Fazal, G.; Goulet, S.; Grandmaitre, C.; Guse, I.; Halmos, T.; Lavallee, P.; Leach, M.; Malenfant, E.; Omeara, J.; Plante, R.; Plouffe, C.; Poirier, M.; Soucy, F.; Yoakim, C.; Deziel, R. Peptidomimetic inhibitors of the human cytomegalovirus protease. J. Med. Chem., 1997, 40, 4113-4135.
[18]
Di Grandi, M.J.; Curran, K.J.; Baum, E.Z.; Bebernitz, G.; Ellestad, G.A.; Ding, W.D.; Lang, S.A.; Rossi, M.; Bloom, J.D. Pyrimido[1,2-b]-1,2,4,5-tetrazin-6-ones as HCMV protease inhibitors: A new class of heterocycles with flavin-like redox properties. Bioorg. Med. Chem. Lett., 2003, 13, 3483-3486.
[19]
Jordao, A.K.; Ferreira, V.F.; Souza, T.M.L.; de Souza, F.G.G.; Machado, V.; Abrantes, J.L.; de Souza, M.C.B.V.; Cunha, A.C. Synthesis and anti-HSV-1 activity of new 1,2,3-triazole derivatives. Bioorg. Med. Chem., 2011, 19, 1860-1865.
[20]
Jordao, A.K.; Afonso, P.P.; Ferreira, V.F.; de Souza, M.C.B.V.; Almeida, M.C.B.; Beltrame, C.O.; Paiva, D.P.; Wardell, S.M.S.V.; Wardell, J.L.; Tiekink, E.R.T.; Damaso, C.R.; Cunha, A.C. Antiviral evaluation of N-amino-1,2,3-triazoles against Cantagalo virus replication in cell culture. Eur. J. Med. Chem., 2009, 44, 3777-3783.
[21]
Wen, Y-N.; Zhang, Z-F.; Liu, N-N.; Andrei, G.; Snoeck, R.; Xiang, Y-H.; Schols, D.; Chen, X.; Zhang, Z-Y.; Zhang, Q-S.; Wu, Q-P. Synthesis and antiviral activity of 5-(benzylthio)-4- carbamyl-1,2,3-triazoles against human cytomegalovirus (CMV) and varicella-zoster virus (VZV). Med. Chem., 2017, 13, 453-464.
[22]
Wen, Y-N.; Zhang, Z-F.; Liu, N-N.; Xiang, Y-H.; Zhang, Z-Y.; Andrei, G.; Snoeck, R.; Schols, D.; Zhang, Q-S.; Wu, Q-P. Synthesis and bioactivity of novel trisubstituted triazole nucleosides. Nucleosid. Nucleotid. Nucl. Acid, 2016, 35, 147-160.
[23]
Wen, Y.; Yuan, W.; Wu, Y.; Chen, X.; Xiang, Y.; Zhang, Zh.; Liu, N.; Andrei, G.; Snoeck, R.; Schols, D.; Wu, Q. Synthesis and antiviral activity of 1,2,3-triazoles. Chin. J. Med. Chem., 2016, 26, 18-24.
[24]
Wen, Y.; Liu, N.; Zhang, Z.; Chen, X.; Yuan, W.; Zhang, Q.; Wu, Q. Synthesis and antitumor activity of multisubstituted triazole derivatives. Chin. J. Med. Chem., 2015, 25, 348-354.
[25]
Gomes, A.T.P.C.; Martins, P.R.C.; Rocha, D.R.; Neves, M.G.P.M.S.; Ferreira, V.F.; Silva, A.M.S.; Cavaleiro, J.A.S.; da Silva, F.D.C. Consecutive tandem cycloaddition between nitriles and azides; synthesis of 5-amino-1H-[1, 2, 3]-triazoles. Synlett, 2013, 24, 41-44.
[26]
Dieudonne-Vatran, A.; Azoulay, M.; Florent, J-C. A new access to 3-substituted-1(2H) -isoquinolone by tandem palladium-catalyzed intramolecular aminocarbonylation annulation. Org. Biomol. Chem., 2012, 10, 2683-2691.
39
3